Jefferies Financial Group Inc. lifted its position in Humana Inc. (NYSE:HUM – Free Report) by 152.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,164 shares of the insurance provider’s stock after purchasing an additional 3,718 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Humana were worth $1,579,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in HUM. Capital International Investors acquired a new stake in shares of Humana in the 3rd quarter valued at about $707,670,000. Bank of New York Mellon Corp raised its position in Humana by 161.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after purchasing an additional 1,060,767 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after purchasing an additional 1,008,514 shares during the last quarter. Neuberger Berman Group LLC raised its position in Humana by 2,855.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock valued at $138,092,000 after purchasing an additional 512,816 shares during the last quarter. Finally, 8 Knots Management LLC raised its position in Humana by 671.0% in the 2nd quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock valued at $107,968,000 after purchasing an additional 384,345 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on HUM. Royal Bank Of Canada boosted their price target on Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research report on Thursday, April 30th. TD Cowen boosted their price target on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research report on Friday, May 1st. Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Truist Financial boosted their price target on Humana from $220.00 to $270.00 and gave the company a “hold” rating in a research report on Thursday, April 30th. Finally, Guggenheim lifted their price objective on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $270.48.
Humana Price Performance
Shares of NYSE:HUM opened at $307.13 on Thursday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a market cap of $36.87 billion, a P/E ratio of 32.85, a PEG ratio of 2.19 and a beta of 0.68. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $315.66. The company has a 50-day moving average price of $226.50 and a 200 day moving average price of $228.10.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue was up 23.5% compared to the same quarter last year. During the same quarter last year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts predict that Humana Inc. will post 9.01 earnings per share for the current year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s dividend payout ratio is presently 37.86%.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
